An in Vitro Pharmacodynamic Model to Simulate Antibiotic Behavior of Acute Otitis Media with Effusion

Kyle Vance-Bryan, Tom A Larson, Mark W. Garrison, John P. Toscano, Daniel M. Canafax, John C Rotschafer

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The purpose of this investigation was to develop an in vitro pharmacodynamic model (IVPM) that would simultaneously simulate in vivo serum and middle ear amoxicillin pharmacokinetic characteristics of acute (purulent) otitis media and then utilize the IVPM to assess amoxicillin-mediated killing of a type 7F Streptococcus pneu-moniae (MIC = 0.002 mg/L). The IVPM consisted of a sterile central compartment and a membrane-bound “infected” peripheral compartment. Peak peripheral compartment amoxicillin concentrations occurred within 2 hr after its introduction into the central compartment and were approximately 30% of peak central compartment concentrations. Amoxicillin elimination from the central compartment was designed to provide a 1-hr t1/2. Amoxicillin elimination from the peripheral compartment was slower than from the central compartment, with an average half-life of 2.3 hr. Significant concentration-related differences in maximal bacterial kill rates were not detected over the range of amoxicillin concentrations studied (0.26 to 14.6 mg/L). However, at peak central compartment amoxicillin concentrations of ≤2 mg/L, a lag phase in killing was observed. In general, the in vitro pharmacokinetic data derived from this model compare well with published in vivo data.

Original languageEnglish (US)
Pages (from-to)920-924
Number of pages5
JournalPharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists
Volume9
Issue number7
DOIs
StatePublished - Jan 1 1992

Fingerprint

Pharmacodynamics
Otitis Media with Effusion
Amoxicillin
Anti-Bacterial Agents
Pharmacokinetics
Suppurative Otitis Media
Middle Ear
In Vitro Techniques
Streptococcus
Half-Life
Membranes
Serum

Keywords

  • amoxicillin
  • in vitro
  • otitis media
  • pharmacodynamics
  • pharmacokinetics

Cite this

An in Vitro Pharmacodynamic Model to Simulate Antibiotic Behavior of Acute Otitis Media with Effusion. / Vance-Bryan, Kyle; Larson, Tom A; Garrison, Mark W.; Toscano, John P.; Canafax, Daniel M.; Rotschafer, John C.

In: Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists, Vol. 9, No. 7, 01.01.1992, p. 920-924.

Research output: Contribution to journalArticle

@article{b6ee0ba9dc8843a2a04ae51aef4399a4,
title = "An in Vitro Pharmacodynamic Model to Simulate Antibiotic Behavior of Acute Otitis Media with Effusion",
abstract = "The purpose of this investigation was to develop an in vitro pharmacodynamic model (IVPM) that would simultaneously simulate in vivo serum and middle ear amoxicillin pharmacokinetic characteristics of acute (purulent) otitis media and then utilize the IVPM to assess amoxicillin-mediated killing of a type 7F Streptococcus pneu-moniae (MIC = 0.002 mg/L). The IVPM consisted of a sterile central compartment and a membrane-bound “infected” peripheral compartment. Peak peripheral compartment amoxicillin concentrations occurred within 2 hr after its introduction into the central compartment and were approximately 30{\%} of peak central compartment concentrations. Amoxicillin elimination from the central compartment was designed to provide a 1-hr t1/2. Amoxicillin elimination from the peripheral compartment was slower than from the central compartment, with an average half-life of 2.3 hr. Significant concentration-related differences in maximal bacterial kill rates were not detected over the range of amoxicillin concentrations studied (0.26 to 14.6 mg/L). However, at peak central compartment amoxicillin concentrations of ≤2 mg/L, a lag phase in killing was observed. In general, the in vitro pharmacokinetic data derived from this model compare well with published in vivo data.",
keywords = "amoxicillin, in vitro, otitis media, pharmacodynamics, pharmacokinetics",
author = "Kyle Vance-Bryan and Larson, {Tom A} and Garrison, {Mark W.} and Toscano, {John P.} and Canafax, {Daniel M.} and Rotschafer, {John C}",
year = "1992",
month = "1",
day = "1",
doi = "10.1023/A:1015857117433",
language = "English (US)",
volume = "9",
pages = "920--924",
journal = "Pharmaceutical Research",
issn = "0724-8741",
publisher = "Springer New York",
number = "7",

}

TY - JOUR

T1 - An in Vitro Pharmacodynamic Model to Simulate Antibiotic Behavior of Acute Otitis Media with Effusion

AU - Vance-Bryan, Kyle

AU - Larson, Tom A

AU - Garrison, Mark W.

AU - Toscano, John P.

AU - Canafax, Daniel M.

AU - Rotschafer, John C

PY - 1992/1/1

Y1 - 1992/1/1

N2 - The purpose of this investigation was to develop an in vitro pharmacodynamic model (IVPM) that would simultaneously simulate in vivo serum and middle ear amoxicillin pharmacokinetic characteristics of acute (purulent) otitis media and then utilize the IVPM to assess amoxicillin-mediated killing of a type 7F Streptococcus pneu-moniae (MIC = 0.002 mg/L). The IVPM consisted of a sterile central compartment and a membrane-bound “infected” peripheral compartment. Peak peripheral compartment amoxicillin concentrations occurred within 2 hr after its introduction into the central compartment and were approximately 30% of peak central compartment concentrations. Amoxicillin elimination from the central compartment was designed to provide a 1-hr t1/2. Amoxicillin elimination from the peripheral compartment was slower than from the central compartment, with an average half-life of 2.3 hr. Significant concentration-related differences in maximal bacterial kill rates were not detected over the range of amoxicillin concentrations studied (0.26 to 14.6 mg/L). However, at peak central compartment amoxicillin concentrations of ≤2 mg/L, a lag phase in killing was observed. In general, the in vitro pharmacokinetic data derived from this model compare well with published in vivo data.

AB - The purpose of this investigation was to develop an in vitro pharmacodynamic model (IVPM) that would simultaneously simulate in vivo serum and middle ear amoxicillin pharmacokinetic characteristics of acute (purulent) otitis media and then utilize the IVPM to assess amoxicillin-mediated killing of a type 7F Streptococcus pneu-moniae (MIC = 0.002 mg/L). The IVPM consisted of a sterile central compartment and a membrane-bound “infected” peripheral compartment. Peak peripheral compartment amoxicillin concentrations occurred within 2 hr after its introduction into the central compartment and were approximately 30% of peak central compartment concentrations. Amoxicillin elimination from the central compartment was designed to provide a 1-hr t1/2. Amoxicillin elimination from the peripheral compartment was slower than from the central compartment, with an average half-life of 2.3 hr. Significant concentration-related differences in maximal bacterial kill rates were not detected over the range of amoxicillin concentrations studied (0.26 to 14.6 mg/L). However, at peak central compartment amoxicillin concentrations of ≤2 mg/L, a lag phase in killing was observed. In general, the in vitro pharmacokinetic data derived from this model compare well with published in vivo data.

KW - amoxicillin

KW - in vitro

KW - otitis media

KW - pharmacodynamics

KW - pharmacokinetics

UR - http://www.scopus.com/inward/record.url?scp=0026763049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026763049&partnerID=8YFLogxK

U2 - 10.1023/A:1015857117433

DO - 10.1023/A:1015857117433

M3 - Article

C2 - 1438006

AN - SCOPUS:0026763049

VL - 9

SP - 920

EP - 924

JO - Pharmaceutical Research

JF - Pharmaceutical Research

SN - 0724-8741

IS - 7

ER -